Kim Leitzel

2.1k total citations
35 papers, 1.6k citations indexed

About

Kim Leitzel is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kim Leitzel has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kim Leitzel's work include HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer Treatment and Pharmacology (8 papers). Kim Leitzel is often cited by papers focused on HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer Treatment and Pharmacology (8 papers). Kim Leitzel collaborates with scholars based in United States, United Kingdom and Austria. Kim Leitzel's co-authors include Allan Lipton, Suhail M. Ali, Walter P. Carney, Laurence M. Demers, A. Lipton, L. Demers, Harold A. Harvey, Rainer Neumann, H Harvey and Y A Teramoto and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Kim Leitzel

34 papers receiving 1.6k citations

Peers

Kim Leitzel
WJ Gullick United Kingdom
Michael Burchmore United States
C Wright United Kingdom
Xenia Jimenez United States
Lisha G. Brown United States
O.O. Melnyk United States
P Bertheau France
Yves Denoux France
Rajiv Bassi United States
Friedrich Otterbach Germany
WJ Gullick United Kingdom
Kim Leitzel
Citations per year, relative to Kim Leitzel Kim Leitzel (= 1×) peers WJ Gullick

Countries citing papers authored by Kim Leitzel

Since Specialization
Citations

This map shows the geographic impact of Kim Leitzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Leitzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Leitzel more than expected).

Fields of papers citing papers by Kim Leitzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Leitzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Leitzel. The network helps show where Kim Leitzel may publish in the future.

Co-authorship network of co-authors of Kim Leitzel

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Leitzel. A scholar is included among the top collaborators of Kim Leitzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Leitzel. Kim Leitzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willumsen, Nicholas, Suhail M. Ali, Kim Leitzel, et al.. (2019). Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer. Scientific Reports. 9(1). 19761–19761. 44 indexed citations
2.
Huang, Jessica, J. W. Chapman, Kim Leitzel, et al.. (2017). Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab). Breast Cancer Research and Treatment. 164(3). 571–580. 11 indexed citations
3.
Alkhateeb, Ahmed, Brian Kinsman, Kim Leitzel, et al.. (2014). Elevation in Multiple Serum Inflammatory Biomarkers Predicts Survival of Pancreatic Cancer Patients with Inoperable Disease. Journal of Gastrointestinal Cancer. 45(2). 161–167. 13 indexed citations
4.
Alkhateeb, Ahmed, Kim Leitzel, Suhail M. Ali, et al.. (2012). Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy. PLoS ONE. 7(12). e51379–e51379. 30 indexed citations
5.
Ghosh, Ritwik, Archana Narasanna, Shizhen Emily Wang, et al.. (2011). Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers. Cancer Research. 71(5). 1871–1882. 171 indexed citations
6.
7.
Bates, Michael, Jeff Sperinde, Wolfgang J. Köstler, et al.. (2011). Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab. Annals of Oncology. 22(9). 2014–2020. 24 indexed citations
8.
9.
Karp, Daniel D., Michaël Pollak, Roger B. Cohen, et al.. (2009). Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin. Journal of Thoracic Oncology. 4(11). 1397–1403. 48 indexed citations
10.
Evans, Matthew, Kim Leitzel, Suhail M. Ali, et al.. (2008). Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy. Breast Cancer Research and Treatment. 119(3). 767–771. 12 indexed citations
11.
Carney, Walter P., Kim Leitzel, Suhail M. Ali, Rainer Neumann, & Allan Lipton. (2007). HER-2 therapy. HER-2/neu diagnostics in breast cancer. Breast Cancer Research. 9(3). 207–207. 40 indexed citations
12.
Leitzel, Kim, Suhail M. Ali, Laurence M. Demers, et al.. (2006). Serum epidermal growth factor receptor/HER‐2 predicts poor survival in patients with metastatic breast cancer. Cancer. 107(10). 2337–2345. 33 indexed citations
13.
Lipton, Allan, Kim Leitzel, Suhail M. Ali, et al.. (2005). Serum HER‐2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy. Cancer. 104(2). 257–263. 81 indexed citations
14.
Carney, Walter P., Rainer Neumann, Allan Lipton, et al.. (2004). Monitoring the Circulating Levels of the HER2/neu Oncoprotein in Breast Cancer. Clinical Breast Cancer. 5(2). 105–116. 61 indexed citations
15.
Ali, Suhail M., Laurence M. Demers, Kim Leitzel, et al.. (2004). Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis. Annals of Oncology. 15(3). 455–459. 50 indexed citations
16.
Lipton, A., Suhail M. Ali, Kim Leitzel, et al.. (2003). Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen. Journal of Clinical Oncology. 21(10). 1967–1972. 102 indexed citations
17.
Lipton, Allan, Suhail M. Ali, Kim Leitzel, et al.. (2002). Serum osteoprotegerin levels in healthy controls and cancer patients.. PubMed. 8(7). 2306–10. 108 indexed citations
18.
Lipton, Allan, Suhail M. Ali, Kim Leitzel, & Daniel F. Hayes. (2001). Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen. Breast Cancer Research and Treatment. 15(1). 82–83. 18 indexed citations
19.
Leitzel, Kim, Y A Teramoto, Kerstin Konrad, et al.. (1995). Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.. Journal of Clinical Oncology. 13(5). 1129–1135. 247 indexed citations
20.
Leitzel, Kim, Y A Teramoto, Beatrice Langton-Webster, et al.. (1992). Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.. Journal of Clinical Oncology. 10(9). 1436–1443. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by WJ Gullick Breakdown of academic impact, for papers by Michael Burchmore Breakdown of academic impact, for papers by C Wright Breakdown of academic impact, for papers by Xenia Jimenez Breakdown of academic impact, for papers by Lisha G. Brown Breakdown of academic impact, for papers by O.O. Melnyk Breakdown of academic impact, for papers by P Bertheau Breakdown of academic impact, for papers by Yves Denoux Breakdown of academic impact, for papers by Rajiv Bassi Breakdown of academic impact, for papers by Friedrich Otterbach
Rankless by CCL
2026